Debating COVID-19 Vaccine Boosters: Public Health Strategy in a Shifting Landscape
Public health authorities in the U.S. are analyzing data on the long-term effectiveness of COVID-19 vaccines and debating the need for vaccine booster shots. This webinar will bring together top experts in public health with different points of view. They will consider federal recommendations on Pfizer-BioNTech, Moderna, and Janssen (Johnson & Johnson) vaccine boosters, and the vaccination of children.
In this highly interactive webinar, panelists will discuss these pressing issues and respond to audience questions.
Eric J. Topol, MD
Executive Vice President
Director & Founder
Scripps Research Translational Institute
Bio: Eric Topol, MD, is an Executive Vice President at Scripps Research and the Founder and Director of the Scripps Research Translational Institute. His work melds genomics, big data, and both information technologies and digital health technologies to advance the promise of personalized medicine. In 2016, the National Institutes of Health awarded Dr. Topol a $207 million grant to lead a significant part of the All of Us Research Program, a long-term research endeavor aimed at understanding how a person’s genetics, environment and lifestyle can guide approaches to preventing or treating disease. Dr. Topol is the author of three bestselling books on the future of medicine: The Creative Destruction of Medicine, The Patient Will See You Now, and Deep Medicine.
Sarah S. Long, MD
Professor of Pediatrics
Drexel University College of Medicine
Emeritus Chief, Section of Infectious Diseases
St. Christopher's Hospital for Children
Bio: Sarah Long, MD, is Professor of Pediatrics at Drexel University College of Medicine and Emeritus Chief of the Section of Infectious Diseases at St. Christopher's Hospital for Children in Philadelphia. Dr. Long has served as Chair of the first Subspecialty Board of Pediatric Infectious Diseases of the American Board of Pediatrics (the national certifying agency for pediatrics and its subspecialties), Chair of the Board of Directors of the American Board of Pediatrics, President of the Pediatric Infectious Diseases Society (the national organization of subspecialists), and President of the Medical Staff at St. Christopher's Hospital for Children. Dr. Long's principal areas of research are vaccine preventable diseases and management of common infectious diseases in children. She sits on research advisory committees for the U.S. Food and Drug Administration, the National Institutes of Health, and the Centers for Disease Control and Prevention.
Yvonne Maldonado, MD
Chief, Division of Pediatric Infectious Diseases
Stanford University School of Medicine
Medical Director, Infection Prevention and Control and Attending Physician
Lucile Packard Children's Hospital at Stanford
Bio: Yvonne (Bonnie) Maldonado, MD, is Professor and Chief of the Division of Infectious Diseases, Department of Pediatrics at Stanford Medicine. She also directs Stanford's Global Child Health Program and serves as the Medical Director of Infection Prevention and Control at Lucile Packard Children's Hospital at Stanford. Dr. Maldonado's research focuses on epidemiologic aspects of viral vaccine development and prevention of perinatal HIV transmission. Her lab is also leading efforts to improve diagnostics and understanding of SARS-COV2 transmission.
Michael T. Osterholm, PhD, MPH
Director, Center for Infectious Disease Research and Policy (CIDRAP)
University of Minnesota
Bio: Michael T. Osterholm, PhD, MPH, is Regents Professor, McKnight Presidential Endowed Chair in Public Health, and Director of the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota. He is a global authority on infectious disease and public health and member of the National Academy of Medicine as well as the Council on Foreign Relations. From June 2018 through May 2019, he served as Science Envoy for Health Security for the U.S. Department of State. In November 2020, Dr. Osterholm was appointed to President-elect Joe Biden's 13-member Transition COVID-19 Advisory Board. He is a frequent consultant to the World Health Organization, National Institutes of Health, Food and Drug Administration, Department of Defense, and CDC.
Susan M. Wolf, JD
Chair, Consortium on Law and Values in Health, Environment & the Life Sciences
University of Minnesota
Bio: Susan M. Wolf, JD, is Regents Professor; McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre Baker Daniels Professor of Law; and Professor of Medicine at the University of Minnesota. She chairs the University’s Consortium on Law and Values in Health, Environment & the Life Sciences and serves as co-lead of the Minnesota COVID Ethics Collaborative (MCEC). Prof. Wolf is a member of the National Academy of Medicine (NAM), fellow of the American Association for the Advancement of Science (AAAS), member of the American Law Institute, and fellow of The Hastings Center.